Expression of N-terminally truncated forms of rat peroxiredoxin-4 in insect cells

Protein Expression and Purification

Volumn 72, Issue 1, 2010, Pages 1-7

  Ikeda, Yoshitaka ^a   Ito, Ritsu ^a   Ihara, Hideyuki ^a   Okada, Takahiro ^a   Fujii, Junichi ^b  

^a SAGA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Baculovirus; Insect cell; Peroxidase; Peroxiredoxin; Polymerization; Signal peptide

Indexed keywords

PEROXIDASE; PEROXIREDOXIN; RECOMBINANT PROTEIN;

ANIMAL; ARMYWORM; ARTICLE; CELL LINE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MUTATION; OXIDATION REDUCTION REACTION; PROTEIN MULTIMERIZATION; RAT;

ANIMALS; CELL LINE; GENE EXPRESSION; MUTATION; OXIDATION-REDUCTION; PEROXIDASE; PEROXIREDOXINS; PROTEIN MULTIMERIZATION; RATS; RECOMBINANT PROTEINS; SPODOPTERA;

HEXAPODA; LEPIDOPTERA; MAMMALIA; RATTUS; SPODOPTERA FRUGIPERDA;

EID: 77951108067     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2010.02.001     Document Type: Article

References (41)

1. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
2. 2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signal. 7 (2005) 619-626
3. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-5152
4. Wang X., Phelan S.A., Forsman-Semb K., Taylor E.F., Petros C., Brown A., Lerner C.P., and Paigen B. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J. Biol. Chem. 278 (2003) 25179-25190
5. Wang Y., Feinstein S.I., Manevich Y., Ho Y.S., and Fisher A.B. Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic. Biol. Med. 37 (2004) 1736-1743
6. Wang Y., Phelan S.A., Manevich Y., Feinstein S.I., and Fisher A.B. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am. J. Respir. Cell. Mol. Biol. 34 (2006) 481-486
7. Iuchi Y., Okada F., Tsunoda S., Kibe N., Shirasawa N., Ikawa M., Okabe M., Ikeda Y., and Fujii J. Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress. Biochem. J. 419 (2009) 149-158
8. Ishii T., Itoh K., Akasaka J., Yanagawa T., Takahashi S., Yoshida H., Bannai S., and Yamamoto M. Induction of murine intestinal and hepatic peroxiredoxin MSP23 by dietary butylated hydroxyanisole. Carcinogenesis 21 (2000) 1013-1016
9. Furuta J., Nobeyama Y., Umebayashi Y., Otsuka F., Kikuchi K., and Ushijima T. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res. 66 (2006) 6080-6086
10. Chang X.Z., Li D.Q., Hou Y.F., Wu J., Lu J.S., Di G.H., Jin W., Ou Z.L., Shen Z.Z., and Shao Z.M. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 9 (2007) R76
11. Iraqui I., Faye G., Ragu S., Masurel-Heneman A., Kolodner R.D., and Huang M.E. Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in Saccharomyces cerevisiae. Cancer Res. 68 (2008) 1055-1063
12. Song I.S., Kim S.U., Oh N.S., Kim J., Yu D.Y., Huang S.M., Kim J.M., Lee D.S., and Kim N.S. Peroxiredoxin I contributes to TRAIL resistance through suppression ofredox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 30 (2009) 1106-1114
13. Neumann C.A., Krause D.S., Carman C.V., Das S., Dubey D.P., Abraham J.L., Bronson R.T., Fujiwara Y., Orkin S.H., and Van Etten R.A. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 (2003) 561-565
14. Demasi A.P., Ceratti D., Furuse C., Cury P., Junqueira J.L., and Araujo V.C. Expression of peroxiredoxin I in plasma cells of oral inflammatory diseases. Eur. J. Oral Sci. 115 (2007) 334-337
15. Yang C.S., Lee D.S., Song C.H., An S.J., Li S., Kim J.M., Kim C.S., Yoo D.G., Jeon B.H., Yang H.Y., Lee T.H., Lee Z.W., El-Benna J., Yu D.Y., and Jo E.K. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J. Exp. Med. 204 (2007) 583-594
16. Li L., Shoji W., Takano H., Nishimura N., Aoki Y., Takahashi R., Goto S., Kaifu T., Takai T., and Obinata M. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem. Biophys. Res. Commun. 355 (2007) 715-721
17. Fang J., Nakamura T., Cho D.H., Gu Z., and Lipton S.A. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc. Natl. Acad. Sci. USA 104 (2007) 18742-18747
18. Yao J., Taylor M., Davey F., Ren Y., Aiton J., Coote P., Fang F., Chen J.X., Yan S.D., and Gunn-Moore F.J. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model. Mol. Cell. Neurosci. 35 (2007) 377-382
19. Qu D., Rashidian J., Mount M.P., Aleyasin H., Parsanejad M., Lira A., Haque E., Zhang Y., Callaghan S., Daigle M., Rousseaux M.W., Slack R.S., Albert P.R., Vincent I., Woulfe J.M., and Park D.S. Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55 (2007) 37-52
20. Fujii J., and Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 7 (2002) 123-130
21. Wood Z.A., Schroder E., Robin Harris J., and Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28 (2003) 32-40
22. Jin D.Y., Chae H.Z., Rhee S.G., and Jeang K.T. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J. Biol. Chem. 272 (1997) 30952-30961
23. Matsumoto A., Okado A., Fujii T., Fujii J., Egashira M., Niikawa N., and Taniguchi N. Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett. 443 (1999) 246-250
24. Okado-Matsumoto A., Matsumoto A., Fujii J., and Taniguchi N. Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem. 127 (2000) 493-501
25. Hall A., Karplus P.A., and Poole L.B. Typical 2-Cys peroxiredoxins - structures, mechanisms and functions. FEBS J. 276 (2009) 2469-2477
26. Barranco-Medina S., Lazaro J.J., and Dietz K.J. The oligomeric conformation of peroxiredoxins links redox state to function. FEBS Lett. 583 (2009) 1809-1816
27. Watabe S., Hiroi T., Yamamoto Y., Fujioka Y., Hasegawa H., Yago N., and Takahashi S.Y. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur. J. Biochem. 249 (1997) 52-60
28. Araki M., Nanri H., Ejima K., Murasato Y., Fujiwara T., Nakashima Y., and Ikeda M. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J. Biol. Chem. 274 (1999) 2271-2278
29. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82 (1985) 488-492
30. Ikeda Y., Fujii J., Taniguchi N., and Meister A. Human gamma-glutamyl transpeptidase mutants involving conserved aspartate residues and the unique cysteine residue of the light subunit. J. Biol. Chem. 270 (1995) 12471-12475
31. Piwnica-Worms H. In: Ausubel F.M., Brent R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. (Eds). Current Protocols in Molecular Biology (1987), Greene Publishing Associates and Wiley-Interscience, New York 16.8.1-16.11.7
32. Felgner P.L., Gadek T.R., Holm H., Roman R., Chan H.W., Wenz M., Northrop J.R., Ringold G.M., and Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84 (1987) 7413-7417
33. Ikeda Y., Fujii J., Taniguchi N., and Meister A. Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc. Natl. Acad. Sci. USA 92 (1995) 126-130
34. Ikeda Y., Fujii J., Anderson M.E., Taniguchi N., and Meister A. Involvement of Ser-451 and Ser-452 in the catalysis of human gamma-glutamyl transpeptidase. J. Biol. Chem. 270 (1995) 22223-22228
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Chae H.Z., Chung S.J., and Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269 (1994) 27670-27678
37. Yang K.S., Kang S.W., Woo H.A., Hwang S.C., Chae H.Z., Kim K., and Rhee S.G. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277 (2002) 38029-38036
38. Tavender T.J., Sheppard A.M., and Bulleid N.J. Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem. J. 411 (2008) 191-199
39. Jarvis D.L., Summers M.D., Garcia Jr. A., and Bohlmeyer D.A. Influence of different signal peptides and prosequences on expression and secretion of human tissue plasminogen activator in the baculovirus system. J. Biol. Chem. 268 (1993) 16754-16762
40. Ikeda Y., Fujii J., Taniguchi N., and Meister A. Expression of an active glycosylated human γ-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc. Natl. Acad. Sci. USA 92 (1995) 126-130
41. Fujii J., Ikeda Y., Watanabe T., Kawasaki Y., Suzuki K., Fujii C., Takahashi M., and Taniguchi N. A defect in the mitochondrial import of mutant Mn-superoxide dismutase produced in Sf21 cells. J. Biochem. 124 (1998) 340-346